Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 2,447.60
+11.30 (0.46%)
Oct 21, 2025, 2:44 PM IST
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 305.68 billion as of October 22, 2025. Its market cap has decreased by -26.96% in one year.
Market Cap
305.68B
Enterprise Value
300.05B
Revenue
48.06B
Ranking
n/a
PE Ratio
32.89
Stock Price
2,447.60
Market Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 305.68B, an increase of 53,925.74%. That is a compound annual growth rate of 30.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 305.68B | -16.53% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | 141.32B | 66.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.06T |
| Divi's Laboratories | 1.75T |
| Cipla | 1.34T |
| Apollo Hospitals Enterprise | 1.15T |
| Mankind Pharma | 1.01T |
| Zydus Lifesciences | 1.01T |
| Fortis Healthcare | 828.87B |
| Alkem Laboratories | 663.29B |